AAAAAA

   
Results: 1-19 |
Results: 19
Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement
Authors: Leitersdorf, E
Citation: E. Leitersdorf, Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement, EUR H J SUP, 3(E), 2001, pp. E17-E23
Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement - Discussion
Authors: Fruchart, JC Leitersdorf, E Shepherd, J Catapano, AL Stein, E
Citation: Jc. Fruchart et al., Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement - Discussion, EUR H J SUP, 3(E), 2001, pp. E24-E25
Clinical-biochemical correlation in molecularly characterized patients with Niemann-Pick type C
Authors: Meiner, V Shpitzen, S Mandel, H Klar, A Ben-Neriah, Z Zlotogora, J Sagi, M Lossos, A Bargal, R Sury, V Carmi, R Leitersdorf, E Zeigler, M
Citation: V. Meiner et al., Clinical-biochemical correlation in molecularly characterized patients with Niemann-Pick type C, GENET MED, 3(5), 2001, pp. 343-348
Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility
Authors: Lievre, M Menard, J Bruckert, E Cogneau, J Delahaye, F Giral, P Leitersdorf, E Luc, G Masana, L Moulin, P Passa, P Pouchain, D Siest, G
Citation: M. Lievre et al., Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility, BR MED J, 322(7286), 2001, pp. 603-605
Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX
Authors: Honda, A Salen, G Matsuzaki, Y Batta, AK Xu, GR Leitersdorf, E Tint, GS Erickson, SK Tanaka, N Shefer, S
Citation: A. Honda et al., Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX, J LIPID RES, 42(2), 2001, pp. 291-300
Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A aremarkedly up-regulated in Cyp27(-/-) mice but not in cerebrotendinous xanthomatosis
Authors: Honda, A Salen, G Matsuzaki, Y Batta, AK Xu, GR Leitersdorf, E Ting, GS Erickson, SK Tanaka, N Shefer, S
Citation: A. Honda et al., Side chain hydroxylations in bile acid biosynthesis catalyzed by CYP3A aremarkedly up-regulated in Cyp27(-/-) mice but not in cerebrotendinous xanthomatosis, J BIOL CHEM, 276(37), 2001, pp. 34579-34585
Transcriptional regulation of the human sterol 27-hydroxylase gene (CYP27)and promoter mapping
Authors: Segev, H Honigman, A Rosen, H Leitersdorf, E
Citation: H. Segev et al., Transcriptional regulation of the human sterol 27-hydroxylase gene (CYP27)and promoter mapping, ATHEROSCLER, 156(2), 2001, pp. 339-347
Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis
Authors: Burnett, JR Moses, EA Coft, KD Brown, AJ Grainger, K Vasikaran, SD Leitersdorf, E Watts, GF
Citation: Jr. Burnett et al., Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis, CLIN CHIM A, 306(1-2), 2001, pp. 63-69
Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: Positive selection is not always necessary to account for disease incidence among Ashkenazi Jews
Authors: Durst, R Colombo, R Shpitzen, S Ben Avi, L Friedlander, Y Wexler, R Raal, FJ Marais, DA Defesche, JC Mandelshtam, MY Kotze, MJ Leitersdorf, E Meiner, V
Citation: R. Durst et al., Recent origin and spread of a common Lithuanian mutation, G197del LDLR, causing familial hypercholesterolemia: Positive selection is not always necessary to account for disease incidence among Ashkenazi Jews, AM J HU GEN, 68(5), 2001, pp. 1172-1188
A new method far determination of serum cholestanol by high-performance liquid chromatography with ultraviolet detection
Authors: Halperin, G Elisaf, M Leitersdorf, E Harats, D
Citation: G. Halperin et al., A new method far determination of serum cholestanol by high-performance liquid chromatography with ultraviolet detection, J CHROMAT B, 742(2), 2000, pp. 345-352
Sterol 27-hydroxylase deficiency: A rare cause of xanthomas in normocholesterolemic humans
Authors: Bjorkhem, I Leitersdorf, E
Citation: I. Bjorkhem et E. Leitersdorf, Sterol 27-hydroxylase deficiency: A rare cause of xanthomas in normocholesterolemic humans, TRENDS ENDO, 11(5), 2000, pp. 180-183
Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia - Reversal by cholic acid feeding
Authors: Repa, JJ Lund, EG Horton, JD Leitersdorf, E Russell, DW Dietschy, JM Turley, SD
Citation: Jj. Repa et al., Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia - Reversal by cholic acid feeding, J BIOL CHEM, 275(50), 2000, pp. 39685-39692
The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge
Authors: Friedlander, Y Leitersdorf, E Vecsler, R Funke, H Kark, J
Citation: Y. Friedlander et al., The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge, ATHEROSCLER, 152(1), 2000, pp. 239-248
Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol
Authors: Kark, JD Sinnreich, R Leitersdorf, E Friedlander, Y Shpitzen, S Luc, G
Citation: Jd. Kark et al., Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol, ATHEROSCLER, 151(2), 2000, pp. 509-518
The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis
Authors: Higazi, AA Nassar, T Ganz, T Rader, DJ Udassin, R Bdeir, K Hiss, E Sachais, BS Williams, KJ Leitersdorf, E Cines, DB
Citation: Aa. Higazi et al., The alpha-defensins stimulate proteoglycan-dependent catabolism of low-density lipoprotein by vascular cells: a new class of inflammatory apolipoprotein and a possible contributor to atherogenesis, BLOOD, 96(4), 2000, pp. 1393-1398
A cholesterol-lowering gene maps to chromosome 13q
Authors: Knoblauch, H Muller-Myhsok, B Busjahn, A Ben Avi, L Bahring, S Baron, H Heath, SC Uhlmann, R Faulhaber, HD Shpitzen, S Aydin, A Reshef, A Rosenthal, M Eliav, O Muhl, A Lowe, A Schurr, D Harats, D Jeschke, E Friedlander, Y Schuster, H Luft, FC Leitersdorf, E
Citation: H. Knoblauch et al., A cholesterol-lowering gene maps to chromosome 13q, AM J HU GEN, 66(1), 2000, pp. 157-166
A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity
Authors: Gervois, P Torra, IP Chinetti, G Grotzinger, T Dubois, G Fruchart, JC Fruchart-Najib, J Leitersdorf, E Staels, B
Citation: P. Gervois et al., A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity, MOL ENDOCR, 13(9), 1999, pp. 1535-1549
Impact of different low-density lipoprotein (LDL) receptor mutations on the ability of LDL to support lymphocyte proliferation
Authors: Martinez-Botas, J Suarez, Y Reshef, A Carrero, P Ortega, H Gomez-Coronado, D Teruel, JL Leitersdorf, E Lasuncion, MA
Citation: J. Martinez-botas et al., Impact of different low-density lipoprotein (LDL) receptor mutations on the ability of LDL to support lymphocyte proliferation, METABOLISM, 48(7), 1999, pp. 834-839
Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population
Authors: Sviri, S Shpizen, S Leitersdorf, E Levy, M Caraco, Y
Citation: S. Sviri et al., Phenotypic-genotypic analysis of CYP2C19 in the Jewish Israeli population, CLIN PHARM, 65(3), 1999, pp. 275-282
Risultati: 1-19 |